Surgical results of only antegrade del Nido cardioplegia infusion in conventional coronary artery bypass grafting: a retrospective study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Additional retrograde cardioplegia infusion in conventional coronary artery bypass grafting (CABG) was introduced to address the concern of inappropriate cardioplegia delivery through the stenotic coronary artery. However, this method is complex and requires repeated infusions. Therefore, we investigated the surgical outcomes of only antegrade cardioplegia infusion in conventional CABG. Methods: We included 224 patients who underwent isolated CABG between 2017 and 2019. The patients were divided into two groups according to the cardioplegia infusion method: antegrade cardioplegia infusion with del Nido solution (n=111, group I) and antegrade+retrograde cardioplegia infusion with blood cardioplegia solution (n=113, group II). Results: The sinus recovery time after release of the aorta cross-clamp was shorter in group I (3.8±7.1 minutes, n=98) than in group II (5.8±4.1 minutes, n=73) (p=0.033). The total cardioplegia infusion volume was lower in group I (1,998.6±668.6 mL) than in group II (7,321.0±2,865.3 mL) (p<0.001). Creatine kinase-MB levels were significantly lower in group I than in group II (p=0.039). Newly developed regional wall motion abnormalities on follow-up echocardiography were detected in two patients (1.8%) in group I and five patients (4.4%) in group II (p=0.233). There was no significant difference in ejection fraction improvement between the two groups (3.3%±9.3% in group I and 3.3%±8.7% in group II, p=0.990). Conclusion: The only antegrade cardioplegia infusion strategy in conventional CABG is safe and has no harmful effects.
Abstract
Background: Additional retrograde cardioplegia infusion in conventional coronary artery bypass grafting (CABG) was introduced to address the concern of inappropriate cardioplegia delivery through the stenotic coronary artery. However, this method is complex and requires repeated infusions. Therefore, we investigated the surgical outcomes of only antegrade cardioplegia infusion in conventional CABG. Methods: We included 224 patients who underwent isolated CABG between 2017 and 2019. The patients were divided into two groups according to the cardioplegia infusion method: antegrade cardioplegia infusion with del Nido solution (n=111, group I) and antegrade+retrograde cardioplegia infusion with blood cardioplegia solution (n=113, group II). Results: The sinus recovery time after release of the aorta cross-clamp was shorter in group I (3.8±7.1 minutes, n=98) than in group II (5.8±4.1 minutes, n=73) (p=0.033). The total cardioplegia infusion volume was lower in group I (1,998.6±668.6 mL) than in group II (7,321.0±2,865.3 mL) (p<0.001). Creatine kinase-MB levels were significantly lower in group I than in group II (p=0.039). Newly developed regional wall motion abnormalities on follow-up echocardiography were detected in two patients (1.8%) in group I and five patients (4.4%) in group II (p=0.233). There was no significant difference in ejection fraction improvement between the two groups (3.3%±9.3% in group I and 3.3%±8.7% in group II, p=0.990). Conclusion: The only antegrade cardioplegia infusion strategy in conventional CABG is safe and has no harmful effects.
참고문헌 (16)
- Guru V, "Is blood superior to crystalloid cardioplegia? : a meta-analysis of randomized clinical trials", Circulation, 114(1 Suppl), pp.I331~8 (2006)
- Flack JE 3rd, "Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? : results from the CABG Patch Trial", Circulation, 102(19 Suppl 3), pp.III84~9 (2000)
- Matte GS, "History and use of del Nido cardioplegia solution at Boston Children’s Hospital", J Extra Corpor Technol, 44, pp.98~103 (2012)
- O’Brien JD, "Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T", Ann Thorac Surg, 87, pp.1517~1523 (2009)
- Govindapillai A, "Protecting the aged heart during cardiac surgery : use of del Nido cardioplegia provides superior functional recovery in isolated hearts", J Thorac Cardiovasc Surg, 146, pp.940~948 (2013)
- Newton DJ, "Mechanisms influencing the vasoactive effects of lidocaine in human skin", Anaesthesia, 62, pp.146~150 (2007)
- Heydarpour M, "Molecular genetics of lidocaine-containing cardioplegia in the human heart during cardiac surgery", Ann Thorac Surg, 106, pp.1379~1387 (2018)
- Perrelli MG, "Ischemia", reperfusion injury and cardioprotective mechanisms : role of mitochondria and reactive oxygen species, 2011, pp.3, 186~200
- Charette K, "Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery procedures", Perfusion, 27, pp.98~103 (2012)
- Ad N, "del Nido cardioplegia : ready for prime time in adult cardiac surgery?", J Thorac Cardiovasc Surg, 149, pp.637~638 (2015)
- Ad N, "The use of del Nido cardioplegia in adult cardiac surgery : a prospective randomized trial", J Thorac Cardiovasc Surg, 155, pp.1011~1018 (2018)
- Ramanathan R, "Use of del Nido cardioplegia in adult cardiac surgery", Thorac Cardiovasc Surg, 63, pp.624~627 (2015)
- Guajardo Salinas GE, "Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery", Perfusion, 32, pp.68~73 (2017)
- Yerebakan H, "Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction : a propensity matched comparison", J Cardiothorac Surg, 9, pp.141~ (2014)
- Timek T, "Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting : initial experience with 100 consecutive patients", Ann Thorac Surg, 101, pp.2237~2241 (2016)
- Timek TA, "Del Nido cardioplegia in isolated adult coronary artery bypass surgery", J Thorac Cardiovasc Surg, 160, pp.1479~1485 (2020)